300841 康华生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资6,5000.00%6,500000
投资性房地产0--0000
固定资产825,965-2.72%849,035461,656248,51774,430
在建工程119,3806.35%112,254523,346238,714127,702
无形资产15,7762.60%15,37617,23318,76621,754
商誉0--0000
其他非流动资产591,5193.92%569,205563,729569,457144,285
1,559,1400.44%1,552,3711,565,9651,075,454368,171

流动资产
货币资金770,075-25.91%1,039,366651,463926,8791,145,491
应收账款1,430,1491.39%1,410,5191,287,074837,177352,683
存货193,76311.66%173,536153,646105,49349,916
其他流动资产26,581-20.60%33,47652,91873,039231,417
2,420,568-8.89%2,656,8972,145,1001,942,5871,779,507

流动负债
短期借款176,402-7.60%190,914109,29600
应付票据0-100.00%4,00017,80400
应付帐款6,21998.75%3,12916,3386,0585,863
其他流动负债346,642-28.33%483,682468,270332,879164,462
529,263-22.36%681,725611,708338,937170,325
流动资产净值1,891,305-4.25%1,975,1731,533,3921,603,6501,609,182
资产总额减流动负债3,450,445-2.19%3,527,5433,099,3572,679,1041,977,353

非流动负债
长期借款0--015,74800
应付债券0--0000
其他非流动负债9,405-30.29%13,4927,9418,8042,919
9,405-30.29%13,49223,6898,8042,919

总权益
    实收股本134,6500.00%134,650134,65090,00060,000
    储备项目3,306,390-2.16%3,379,4012,941,0182,580,3011,914,434
股东权益3,441,040-2.08%3,514,0523,075,6682,670,3011,974,434
非控股权益0--0000